Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease
Clinical trial NCT05243017 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05243017
- Sponsor
- UniQure Biopharma B.V.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-07
- Primary completion
- 2029-03-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.